V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002734 | 240007291 | 1.73 | 68.2 | null | 2019-11-07 | 2019-12-01 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 01 | null | ANAGRELIDE | 100505346 |
| 240002739 | 240007293 | 1.62 | 54.1 | null | 2019-07-30 | 2019-07-30 | Imatinib 400mg | 02 | null | PEG INTERFERON | 100407138 |
| 240002741 | 240007295 | 1.58 | 9.5 | Curative (C) | null | 2017-06-04 | ALL UKALL2011 Aug BFM Cons C PegAsp | N | N | AML MYECHILD 01 IT CYT | 100903476 |
| 240002743 | 240007296 | 1.62 | 64.4 | Curative (C) | 2020-01-06 | 2020-01-14 | null | 01 | null | DABRAFENIB | 100930548 |
| 240002749 | 240007298 | 0 | 27.3 | Curative (C) | 2017-02-04 | 2017-02-12 | null | 02 | N | DASATINIB | 100684038 |
| 240002751 | 240007300 | 1.76 | 90.3 | Curative (C) | 2020-03-07 | 2020-06-04 | UKALL14- Intens/CNS Proph +Imatinib | 02 | null | RUXOLITINIB | 100637756 |
| 240002752 | 240007301 | 1.78 | 47.6 | Curative (C) | 2019-05-24 | 2019-05-31 | Cyclophosphamide High Dose | 02 | N | FLAIR TRIAL | 101242258 |
| 240002753 | 240007302 | null | 46.6 | null | 2017-10-15 | 2017-10-26 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | NOT MATCHED | 101488863 |
| 240002754 | 240007303 | 1.62 | 78.7 | Palliative (P) | 2017-06-04 | 2017-06-06 | AML Interim Guidelines FLAG-Ida | 02 | N | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100630392 |
| 240002760 | 240007307 | 1.73 | 56 | Curative (C) | null | 2020-12-17 | null | null | N | BUSULFAN | 101835631 |
| 240002761 | 240007308 | null | 73.5 | Curative (C) | null | 2017-08-16 | ALL ALLR3: HR Con: Wk 7-10 (PegAsp) | 02 | N | PEG INTERFERON | 101043271 |
| 240002766 | 240007311 | 1.75 | 128.6 | null | 2019-06-05 | 2019-06-09 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | null | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 100669676 |
| 240002768 | 240007313 | 1.65 | 66.6 | null | 2017-04-12 | 2018-02-11 | ALL UKALL2011 Std BFM Cons B | 2 | null | CYTARABINE + FLUDARABINE + IDARUBICIN | 100081712 |
| 240002769 | 240007314 | 1.68 | null | Disease modification (D) | 2020-10-31 | 2020-11-30 | LEAM | Y | null | CLADRIBINE | 101138675 |
| 240002771 | 240007316 | 1.83 | 71.8 | null | 2020-08-22 | 2020-09-06 | Trial Unspecified | 02 | null | IMATINIB | 100305241 |
| 240002772 | 240007317 | 1.55 | 78.4 | null | 2018-12-06 | 2018-12-12 | CNS Low Grade Glioma Vinblastine | 02 | null | STS RHABDO RMS 2005 VIN CYCLO | 101375285 |
| 240002773 | 240007318 | 1.52 | 21 | null | 2019-09-13 | 2019-10-21 | Cyclophosphamide TBI Allograft | 02 | N | CYCLOPHOSPHAMIDE | 101607667 |
| 240002775 | 240007319 | 1.68 | 74.8 | null | 2016-08-29 | 2016-09-04 | R CODOX-M/ R IVAC | 01 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101733692 |
| 240002776 | 240007320 | null | null | null | 2016-08-29 | 2016-09-03 | NHL Inter B NHL ritu 2010 C CYVE1,2 | 02 | null | AZACITIDINE + VENETOCLAX | 100573657 |
| 240002779 | 240007322 | 1.69 | 16.4 | Curative (C) | 2018-07-22 | 2018-09-03 | NHL 2003 Gp B CYM 1 & 2 | N | null | RUXOLITINIB | 101576750 |
| 240002780 | 240007323 | 0 | 106 | Curative (C) | null | 2017-05-02 | ALL UKALL2011 IndB Std Dex (PegAsp) | null | null | GEMTUZUMAB OZOGAMICIN | 101807235 |
| 240002782 | 240007325 | 1.63 | 66.9 | null | 2017-04-17 | 2017-04-18 | null | 02 | null | RUXOLITINIB | 100381221 |
| 240002786 | 240007326 | 1.57 | 124.6 | Curative (C) | null | 2017-07-13 | null | null | N | CYTARABINE HIGH DOSE | 100601343 |
| 240002787 | 240007327 | 1.68 | 61 | null | 2019-08-15 | 2019-08-21 | Methotrexate intrathecal | Y | null | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 100469034 |
| 240002788 | 240007328 | 1.81 | 79.4 | null | 2020-02-04 | 2020-02-10 | AML16 DA 3+8 | 02 | null | CLADRIBINE | 101542502 |
| 240002791 | 240007331 | 1.54 | 86 | Curative (C) | null | 2016-09-06 | Cisplatin+Gemcitabine (gallbladder) | null | N | AML MYECHILD 01 IT CYT | 101162074 |
| 240002792 | 240007332 | null | 60.2 | null | 2017-02-02 | 2017-02-03 | Alemtuz+Fludara+Melphalan RIC MUD | 01 | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101631337 |
| 240002798 | 240007335 | 1.76 | 0 | null | 2016-09-13 | 2016-09-21 | GEMCITABINE + RITUXIMAB | 02 | N | IMATINIB | 100442675 |
| 240002800 | 240007337 | 1.66 | 94 | Palliative (P) | 2019-12-29 | 2019-12-29 | null | 02 | N | BORTEZOMIB | 101636520 |
| 240002803 | 240007340 | 1.6 | 104.4 | null | null | 2017-06-16 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | null | AML MYECHILD 01 FLA-IDARUBICIN | 101292001 |
| 240002804 | 240007341 | 1.84 | 22.55 | null | 2019-03-01 | 2019-12-12 | METHOTREXATE + PEGASPARGASE | 02 | null | METHOTREXATE + PEGASPARAGINASE | 100823128 |
| 240002805 | 240007342 | 1.81 | 18.2 | Curative (C) | 2020-03-10 | 2020-03-11 | null | 02 | N | GEMTUZUMAB OZOGAMICIN | 100141254 |
| 240002811 | 240007344 | 1.62 | 66.9 | null | 2018-05-30 | 2018-10-10 | CNS Low Grade Glioma Vinblastine | Y | null | IBRUTINIB | 101321394 |
| 240002815 | 240007345 | 1.77 | 52.9 | null | null | 2019-12-09 | CYTARABINE + DAUNORUBICIN + Gemtuzumab Ozogamicin | null | null | CNS LGG2004 03 VINC + CARBO | 100137843 |
| 240002816 | 240007346 | 1.65 | 10 | null | 2019-01-22 | 2019-01-31 | METHOTREXATE + PEGASPARGASE | null | null | NOT MATCHED | 100165288 |
| 240002817 | 240007347 | 1.57 | 89.5 | null | 2018-05-31 | 2018-08-04 | null | 02 | null | NOT MATCHED | 100255854 |
| 240002818 | 240007348 | 1.85 | 46.3 | null | 2018-10-04 | 2018-10-05 | DA 3 + 10 | 02 | null | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100719992 |
| 240002820 | 240007349 | 1.77 | 122.4 | null | 2019-10-04 | 2019-11-03 | Methotrexate intrathecal | 02 | null | BENDAMUSTINE | 100058537 |
| 240002825 | 240007352 | 1.62 | 28.05 | null | 2016-07-28 | 2016-08-12 | CLOFARABINE + MELPHALAN | Y | N | METHOTREXATE INTRATHECAL | 100345964 |
| 240002826 | 240007353 | null | 62.5 | Curative (C) | 2018-08-06 | 2018-08-25 | AML Interim Guidelines FLAG-Ida | 02 | N | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 101539970 |
| 240002828 | 240007355 | 1.71 | 28.05 | 03 | null | 2019-03-07 | AML MyeChild 01 A Mitozantrone/Cytarabine | N | N | UKALL2011 | 101370497 |
| 240002830 | 240007357 | 1.66 | 91.6 | null | null | 2022-02-21 | ICE-R | null | null | CYTARABINE HIGH DOSE | 100893645 |
| 240002831 | 240007358 | 1.83 | 82.8 | null | 2016-12-06 | 2017-01-15 | ALL Interim Guide 2019 Consolidation A | 02 | null | NILOTINIB | 100005624 |
| 240002833 | 240007359 | 1.76 | 44.8 | Curative (C) | 2021-12-14 | 2021-12-17 | Methotrexate intrathecal | 02 | N | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 100879286 |
| 240002839 | 240007361 | 1.82 | 55.9 | null | 2018-10-11 | 2018-10-16 | null | 02 | null | CYTARABINE + METHOTREXATE | 100264509 |
| 240002841 | 240007362 | 1.84 | 83.4 | Curative (C) | 2018-11-01 | 2018-11-01 | DA 3+8 | 02 | null | CYTARABINE + FLUDARABINE + IDARUBICIN | 100670116 |
| 240002842 | 240007363 | 1.86 | null | Palliative (P) | null | 2016-08-03 | VEDex | N | N | RUXOLITINIB | 100854412 |
| 240002844 | 240007365 | 1.77 | 100.9 | Curative (C) | 2019-05-08 | 2019-05-23 | AML16 DA 3+10 | 02 | N | BUSULFAN | 100157504 |
| 240002847 | 240007368 | 1.85 | null | null | 2021-05-11 | 2021-09-29 | RUXOLITINIB | 02 | null | FLUDARABINE + MELPHALAN | 100938743 |
| 240002848 | 240007369 | 1.62 | 79 | Disease modification (D) | 2016-10-09 | 2016-11-15 | Clofarabine + Cytarabine | 02 | null | FLUDARABINE + THIOTEPA + TREOSULFAN | 101120173 |